CAPTRUST Financial Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,143
| Closed | -$21.9K | – | 2571 |
|
|
2025
Q1 | $21.9K | Buy |
2,143
+1,343
| +168% | +$13.7K | ﹤0.01% | 2317 |
|
|
2024
Q4 | $11.2K | Sell |
800
-50
| -6% | -$698 | ﹤0.01% | 2278 |
|
|
2024
Q3 | $16.6K | Buy |
850
+50
| +6% | +$975 | ﹤0.01% | 2263 |
|
|
2024
Q2 | $14.9K | Hold |
800
| – | – | ﹤0.01% | 2177 |
|
|
2024
Q1 | $11.2K | Sell |
800
-2
| -0.2% | -$28 | ﹤0.01% | 2121 |
|
|
2023
Q4 | $6.79K | Sell |
802
-409
| -34% | -$3.47K | ﹤0.01% | 2641 |
|
|
2023
Q3 | $10.8K | Buy |
1,211
+239
| +25% | +$2.14K | ﹤0.01% | 2536 |
|
|
2023
Q2 | $8.39K | Sell |
972
-307
| -24% | -$2.65K | ﹤0.01% | 2487 |
|
|
2023
Q1 | $13.5K | Buy |
+1,279
| New | +$13.5K | ﹤0.01% | 2263 |
|
|
2022
Q4 | – | Sell |
-1,537
| Closed | -$74K | – | 2142 |
|
|
2022
Q3 | $74K | Buy |
1,537
+1,318
| +602% | +$63.5K | ﹤0.01% | 1962 |
|
|
2022
Q2 | $13K | Buy |
219
+24
| +12% | +$1.43K | ﹤0.01% | 3609 |
|
|
2022
Q1 | $16K | Buy |
195
+66
| +51% | +$5.42K | ﹤0.01% | 3532 |
|
|
2021
Q4 | $26K | Buy |
129
+18
| +16% | +$3.63K | ﹤0.01% | 3119 |
|
|
2021
Q3 | $30K | Buy |
111
+3
| +3% | +$811 | ﹤0.01% | 2903 |
|
|
2021
Q2 | $28K | Hold |
108
| – | – | ﹤0.01% | 2888 |
|
|
2021
Q1 | $32K | Buy |
108
+85
| +370% | +$25.2K | ﹤0.01% | 2702 |
|
|
2020
Q4 | $6K | Buy |
23
+4
| +21% | +$1.04K | ﹤0.01% | 2780 |
|
|
2020
Q3 | $5K | Buy |
+19
| New | +$5K | ﹤0.01% | 2534 |
|
|
2019
Q3 | – | Sell |
-4
| Closed | -$2K | – | 2000 |
|
|
2019
Q2 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 1811 |
|